Prostate Cancer

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer

By

Patients who practiced Eischens yoga twice a week had less fatigue, sexual dysfunction, and certain scores related to quality of life.

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer

By

Several clinical societies came together to create appropriate use criteria for the use of bone scintigraphy in patients with prostate and breast cancer.

PSA Screening Rates Level Off in United States

PSA Screening Rates Level Off in United States

Decline in prostate-specific antigen (PSA) screening followed U.S. Preventive Services Task Force recommendations.

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

By

Family history does not predict aggressiveness of prostate cancer or suitability for active surveillance as a treatment option.

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases

By

Abiraterone acetate and prednisone reduced PSA levels in a small group of clinical trial participants with metastatic prostate cancer who did not initially respond to ADT.

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

Yoga Can Help Ease Side Effects of Prostate Cancer Treatment

patients with prostate cancer who attended yoga classes had less fatigue and better sexual and urinary function.

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

E4 Steroid Reduces Testosterone Levels, Treats Advanced Prostate Cancer

By

Steroid produced by human fetal liver reduces testosterone levels, holding potential as treatment for advanced prostate cancer.

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

Disparities Growing in Prescreening Discussions About Prostate-Specific Antigen Testing

By

Conversations about benefits and drawbacks of PSA testing improved after the USPSTF updated its recommendations on PSA testing; however, some disparities in quality of these discussions increased.

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

Prostate Cancer Response to Immunotherapy Improved With Combination Therapy

By

Immunotherapy alone is not effective in prostate cancer; however, combining it with PD-1/PD-L1 and VISTA inhibitors is effective.

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

ASCO, Cancer Care Ontario Update Recommendations on Brachytherapy in Prostate Cancer

By

ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

VERT Program Eases Patient Anxiety, Improves Understanding of Treatment for Prostate Cancer

By

Virtual Environment Radiotherapy (VERT) program eases anxiety and improves understanding of radiation therapy for patients with prostate cancer.

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

Little Difference in QoL Between Various Treatments, Active Surveillance in Prostate Cancer

By

QoL after radical prostatectomy, EBRT, or brachytherapy vs active surveillance for prostate cancer are similar.

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

Interactive App Helps Manage Prostate Cancer Treatment Symptoms

By

Interactive app helps patients with prostate cancer manage their treatment-related symptoms.

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer

By

Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

Fluciclovine PET/CT Improves Targeted Radiation Treatment of Recurrent Prostate Cancer

By

F-18-fluciclovine PET helps detect and localize recurrent prostate cancer allowing for individualized, targeted therapy.

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer

By

A single 19-Gy fraction of brachytherapy was found as effective as a longer regimen of low-dose-rate brachytherapy in localized prostate cancer.

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer

By

Cabozantinib activated innate immunity and completely eradicated prostate cancer in a study using a mouse model.

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

By

Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.

No Association Between Vasectomy and Prostate Cancer Risk

No Association Between Vasectomy and Prostate Cancer Risk

By

There is no association between vasectomy and the risk of overall, high-grade, or advanced-stage prostate cancer or prostate cancer-related mortality.

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

Low-Fat Meal May Allow for Lower Doses of Abiraterone Acetate in Prostate Cancer Patients

By

A lower dose of abiraterone acetate with a low fat meal may have the same effect as taking the standard dose as recommended on an empty stomach.

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure

By

Treatment expectations of individuals with metastatic prostate cancer and their health care providers often do not match.

Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer

Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer

By

African American men choosing active surveillance for their low-grade prostate cancer have overall poorer health than non-African American men undergoing active surveillance.

Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals

Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals

By

A significant difference exists in the failure to follow-up rates among patients undergoing active surveillance at university-based hospitals versus safety-net hospitals.

Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis

Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis

By

The Decipher genomic classifier obtained from biopsy samples was prognostic for distant metastases and prostate cancer-specific mortality.

GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible

GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible

By

A phase 3 study presented at the 2017 Genitourinary Cancers Symposium demonstrated the feasibility of conducting adjuvant trials.

Immunotherapy and the Future of Prostate Cancer Treatment

Immunotherapy and the Future of Prostate Cancer Treatment

By

Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer.

Targeting AR Mutations Promising in Metastatic Prostate Cancer

Targeting AR Mutations Promising in Metastatic Prostate Cancer

By

A higher overall number of genetic alterations in cell-free circulating tumor DNA (ctDNA) were associated with worse treatment outcomes.

Adding Bicalutamide to Salvage RT Improves OS in Recurrent Prostate Cancer

Adding Bicalutamide to Salvage RT Improves OS in Recurrent Prostate Cancer

By

Investigators studied the effects of adding antiandrogen therapy to radiotherapy on cancer control and overall survival in men with prostate cancer recurrence after radical prostatectomy.

Clinicians May Want To Address Emotional Stress to Prevent Overtreatment of Localized Prostate Cancer

Clinicians May Want To Address Emotional Stress to Prevent Overtreatment of Localized Prostate Cancer

By

Some men with low-risk prostate cancer may opt for more aggressive treatments due to emotional distress.

Prostate Cancer Treatment Rates Decrease Following Changes in Treatment Recommendations

Prostate Cancer Treatment Rates Decrease Following Changes in Treatment Recommendations

By

The implementation of recommendations opposing regular prostate cancer screening appear to have lowered treatment rates dramatically.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs